Screening, Classification, and Outcome Prediction Ensemble Using Orbital MRI for Thyroid Eye Disease: The TED SCOPE National Multicenter Registry Study

Recruiting Observational Study
Graves Ophthalmopathy Graves Disease Thyroid Associated Ophthalmopathies
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Observational
Participants needed
1,200 (estimated)
Sponsor
Shanghai Changzheng Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to prospectively validate the efficacy of an AI multimodal model constructed based on multi - sequence orbital MRI in the diagnosis, activity and severity assessment, and prognosis prediction of thyroid - associated ophthalmopathy (TAO) in real - world clinical scenarios. The main questions it aims to answer are: Can AI models accurately assess the presence…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * TAO patient group * Age between 18 and 75 years old, regardless of gender. * Patients with thyroid eye disease who meet the disease staging and grading criteria specified in diagnostic guidelines such as those of Bartley, CAS, and EUGOGO. * The patient has plann…
Contacts

Tuo Li, Vice Professor

+86-13918507887

zoe_leeto@hotmail.com

CONTACT